genXone S.A. (WSE:GX1)

Poland · Delayed Price · Currency is PLN

5.30

-0.06 (-1.12%)

Last updated: Sep 18, 2026, 4:30 PM CET

Market Cap	17.52M -2.9%
Revenue (ttm)	2.48M +24.2%
Net Income	-2.18M
EPS	-0.66
Shares Out	3.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	294
Open	5.38
Previous Close	5.36
Day's Range	5.18 - 5.38
52-Week Range	3.81 - 6.96
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About genXone

genXone S.A. operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It also develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. was incor... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 2018

Employees 17

Stock Exchange Warsaw Stock Exchange

Ticker Symbol GX1

Full Company Profile

Financial Performance

In 2025, genXone's revenue was 2.34 million, an increase of 31.07% compared to the previous year's 1.79 million. Losses were -2.64 million, -32.78% less than in 2024.

Financial Statements